1. A Rare Case of Migratory Urticaria Causing Dysphagia During an Acute Flare of Ulcerative Colitis: 2077. (October 2019) Authors: Alexis, Jamil O.; Qiu, He; Shen, Janice G.; Sultan, Keith Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Rare Cause of Small Bowel Obstruction: 2422. (October 2017) Authors: Patel, Anish V.; Jotwani, Pooja M.; Sultan, Keith Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An elderly patient's complete response to steroid therapy for collagenous gastritis. (August 2018) Authors: Lim, Huei-Wen; Wong, Benny Yiu; Elkowitz, David; Sultan, Keith Journal: Therapeutic advances in chronic disease Issue: Volume 9:Number 8(2018) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (18th October 2019) Authors: Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua... Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes. Issue 11 (3rd May 2019) Authors: Koliani-Pace, Jenna L; Singh, Siddharth; Luo, Michelle; Hirten, Robert; Aniwan, Satimai; Kochhar, Gursimran; Chang, Shannon; Lukin, Dana; Gao, Youran; Bohm, Matthew; Swaminath, Arun; Gupta, Nitin; Shmidt, Eugenia; Meserve, Joseph; Winters, Adam; Chablaney, Shreya; Faleck, David M; Yang, Jiao; Hua... Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 11(2019) Page Start: 1854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Correction: Vedolizumab for Ulcerative Colitis. (April 2019) Authors: Narula, Neeraj; Peerani, Farhad; Meserve, Joseph; Kochhar, Gursimran; Chaudrey, Khadija; Hartke, Justin; Chilukuri, Prianka; Koliani-Pace, Jenna; Winters, Adam; Katta, Leah; Shmidt, Eugenia; Hirten, Robert; Faleck, David; Parikh, Malav P.; Whitehead, Diana; Boland, Brigid S.; Singh, Siddharth; Sa... Journal: American journal of gastroenterology Issue: Volume 114:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study. (November 2022) Authors: Hong, Simon J.; Bhattacharya, Sumona; Aboubakr, Aiya; Nadkarni, Devika; Lech, Diana; Ungaro, Ryan C.; Agrawal, Manasi; Hirten, Robert P.; Greywoode, Ruby; Mone, Anjali; Chang, Shannon; Hudesman, David P.; Ullman, Thomas; Sultan, Keith; Lukin, Dana J.; Colombel, Jean-Frederic; Axelrad, Jordan E. Journal: Therapeutic advances in gastroenterology Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors. Issue 5 (20th January 2019) Authors: Agrawal, Manasi; Cohen‐Mekelburg, Shirley; Kayal, Maia; Axelrad, Jordan; Galati, Jonathan; Tricomi, Brad; Kamal, Kanika; Faye, Adam S.; Abrudescu, Paul; Scherl, Ellen; Lawlor, Garrett; Sultan, Keith; Lukin, Dana; Colombel, Jean‐Frederic; Ungaro, Ryan C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 49:Issue 5(2019) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022) Authors: Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022) Authors: Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗